Page 8 - Diet And Dementia Casein Antioxidants DHEA
P. 8

Fecal Bifidobacterium               Fecal Lactobacillus
                    Group                 CFU log 10/g feces                CFU log 10/g feces
                                   Baseline    2 Weeks     P-Value    Baseline   2 Weeks     P-Value

             Prebiotic Fiber Blend    8.3         9.1       0.03        10.3        11.1      0.04
                  FortiFlora® ®       8.3        9.3        <0.01       10.3        11.3       0.01

                Prostora®  Max        8.3        9.6        <0.01       10.3        11.5      <0.01
                         ™
                   Control            8.4        8.5        0.58        10.4       10.5        0.67

            Table 1. Mean fecal Bifidobacterium and Lactobacillus concentrations for control food+prebiotic fiber blend, control food+FortiFlora®, control food+Prostora™ Max,
             and control food groups at baseline and after 2 weeks of treatment. P-values represent the difference between baseline and 2 weeks.





                                                                 Dogs were randomly assigned to either the
               Effects of alpha-casozepine (Zylkene)             alpha-casozepine (test) or selegiline group.
               versus selegiline hydrochloride                   The test group received 15 mg/kg body weight
               (Selgian, Anipryl) on anxiety                     (BW) of alpha-casozepine orally once a day,
               disorders in dogs 5                               while the selegiline group received 0.5 mg/kg
                                                                 BW orally once a day. Dogs in both groups
                                                                 were also provided behavioral modification.
            STUDY OBJECTIVE                                      Each dog was evaluated 5 times during the

            The purpose of this study was to determine if        56-day study. Evaluations were performed
            the natural biological agent alpha-casozepine        initially and at weeks 4 and 8 in the hospital;
            (hydrolyzed casein) has the same anxiolytic          telephone evaluations occurred at weeks 2 and
            effect as selegiline, a monoamine oxidase            6. Two separate categories were tracked at each
            inhibitor (MAOI) used for the treatment of           evaluation: EDED score and owner’s subjective
            anxiety disorders and cognitive dysfunction          evaluation of change. Positive results were
            in dogs.                                             defined as an EDED score < 20 and owner’s
                                                                 subjective evaluation score ≥ 6/10. Successful
                                                                 treatment had to meet both criteria.
            STUDY DESIGN
            This study was a multicenter, randomized,            RESULTS
            blinded, comparative trial. Dogs were
            evaluated for anxiety by using a validated dog       Thirty-eight dogs (19 female, 19 male)
            emotional scale (Emotional Disorder Evaluation       completed the study. Overall, there were 19
            for Dogs or EDED). Dogs diagnosed with an            successes: 10 dogs in the alpha-casozepine
            anxiety-related behavior that had persisted          group and 9 dogs in the selegiline group.
            for >4 weeks and which had a total score of          No significant difference existed between
            >19 out of 45 points on the EDED scale were          the two groups; alpha-casozepine &
            included in the study. Owners subjectively           selegiline were equally effective in treating
            evaluated and scored their dog’s behavior            anxiety based on both EDED scores and
            throughout the study on a scale of -10 to 10.        owners’ evaluations. There was a significant
                                                                 (P<0.0001) decrease in average EDED score
                                                                 between the initial visit and week 8 for both
                                                                 treatment groups (Figure 2). Evaluators
                                                                 were unable to determine treatment
                                                                 success until at least the 6-week evaluation;
                                                                 however, a trend did show improvement in
                                                                 EDED score starting as early as day 15.
   3   4   5   6   7   8   9   10   11   12   13